ArticleFrontiers in endocrinology2026
Clinical indices and anthropometric measures for magnetic resonance imaging-defined visceral adiposity across the hypercortisolism spectrum.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Conventional anthropometric measures may inadequately capture metabolically relevant fat redistribution in hypercortisolism. We evaluated the discriminative performance of clinical indices (Hepatic Steatosis Index [HSI], Visceral Adiposity Index [VAI], Metabolic Score for Visceral Fat [METS-VF]) and anthropometric measures (body mass index [BMI], waist circumference) for MRI-defined visceral adiposity across the hypercortisolism spectrum. Design and methods: In this cross-sectional study, 65 participants were included: 13 with active Cushing's disease (CD), 12 with CD in remission, 30 with mild autonomous cortisol secretion (MACS), and 10 healthy controls. Abdominal MRI with proton density fat fraction separately quantified visceral (VAT), hepatic, and pancreatic fat. Index performance for visceral adiposity (VAT >130 cm²) was assessed among participants with hypercortisolism (n=55). Results: VAT differed across groups (p=0.02), highest in MACS (230.8 [164.9-292.4] cm²). VAT was associated with HOMA-IR (r=0.5, p=0.009) and HbA1c (r=0.4, p=0.001) but not with circulating cortisol. Hepatic and pancreatic fat did not differ across groups; hepatic fat correlated with HOMA-IR and pancreatic fat with HbA1c, but neither with cortisol. HSI was the only index reaching significance for visceral adiposity (AUC 0.82, 95% CI: 0.68-0.96, p=0.002), at a cohort-derived cut-off of 39.25 (sensitivity 87%, positive predictive value 93%); METS-VF, BMI, and waist circumference did not (all p≥0.1). Among participants without obesity (BMI <30 kg/m², n=31), HSI classification remained associated with visceral adiposity (p=0.001). Conclusion: In endogenous hypercortisolism, ectopic fat distribution was more closely associated with metabolic burden rather than cortisol levels. HSI may have potential as an exploratory screening adjunct for occult visceral adiposity, particularly in patients without obesity, pending external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.